Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Liebens

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Human Reproduction (Oxford, England)|October 20, 2006
Safety of hormone therapy after breast cancer: a qualitative systematic reviewC Antoine, F Liebens, B Carly, et al.
Climacteric : the Journal of the International Menopause Society|July 23, 2008
A survey among breast cancer survivors: treatment of the climacteric after breast cancerC Antoine, J Vandromme, M Fastrez, et al.
Acta Chirurgica Belgica|August 10, 2007
Treatment of premature menopause in breast cancer patientsG Deniz, C Antoine, F Liebens, et al.
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)|September 27, 2008
Current management of lobular in situ neoplasiaF Liebens, A S Cardinael, A P Schillings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancerM J Piccart, A Di Leo, M Beauduin, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Human Reproduction (Oxford, England)|October 20, 2006
Safety of hormone therapy after breast cancer: a qualitative systematic reviewC Antoine, F Liebens, B Carly, et al.
Climacteric : the Journal of the International Menopause Society|July 23, 2008
A survey among breast cancer survivors: treatment of the climacteric after breast cancerC Antoine, J Vandromme, M Fastrez, et al.
Acta Chirurgica Belgica|August 10, 2007
Treatment of premature menopause in breast cancer patientsG Deniz, C Antoine, F Liebens, et al.
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)|September 27, 2008
Current management of lobular in situ neoplasiaF Liebens, A S Cardinael, A P Schillings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancerM J Piccart, A Di Leo, M Beauduin, et al.
Pageof 2